Ropes & Gray advised biopharmaceutical firm CANbridge Pharmaceuticals Inc. on the deal CANbridge Pharmaceuticals Inc. closed an exclusive licensing agreement in China with GC Pharma, a…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
